Register before February 2nd & Save €500
Data dictates payer decisions and has the potential to provide a new guiding light for pharma companies. We want to create a summit that catalyses the healthcare landscape into a new world. A place complete with real-world insights, aiding in the creation of true value in the eyes of the payers and regulators, and allowing patients the access to the drugs and treatments they need most.
At the Real-World Evidence and Access Europe 2018 Summit We will once again bring together the leading thought leaders and biggest industry case studies from across the continent, while also moving to ensure that speaking and participating will be all the key decision-makers in full stakeholder environment – complete with regulators, payers and HTAs.
Download the detailed event brochure here
Deputy Chief Executive
Head, Global Commercial and Market Access Strategy Organisation
Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada
Global Market Access Director, Neurology
Director Greater Manchester
Director of Real World Evidence
Senior Director Health Information Sciences
Head of Real World Evidence, Centre of Excellence
The 2018 summit will bring you 2 conferences in one.
One completely dedicated to market access, innovative pricing and re-imbursement and the other track dedicated to expanding the use of RWE internally across functions and influencing external decision makers
“The event covered most of the key aspects related to RWE. I think, it was very useful. I definitely learned a lot.”
Antonio Ramirez de Arellano, Lead EU-HEOR, Novo Nordisk
“This was one of the most relevant and comprehensive conferences, which I have attended in recent years. The speakers and meeting chairs were well selected.”
Karel Mechelse, Market Access Strategy Leader, Bayer
“Well worth investing in... a place to exchange views and perspectives”
Frederic de Reydet, Global Market Access Director, Novartis
“An excellent representation of key European decision makers”
Myriam Zylberman, Senior Director - EU Payer Strategy, Eli Lilly
“A fascinating meeting of diverse speakers who outlined numerous themes around the need to prove the validity and trustworthiness of RWE, versus RCTs, with an emphasis on “real time” versus “real world”. Thank you eyeforpharma!”
Nigel Hughes, Scientific Director, Janssen
If you’re interested in getting involved in the 2018 summit, please contact us on the details below.
Global Project Director
Phone: +44 (0) 207 375 7163
Phone: +44 (0) 207 375 7203
eyeforpharma is a registered company in England and Wales - Registered number 09823909. 7-9 Fashion Street, London, E1 6PX, UK. Contact Us.
Website Development by Fruitbowl Media Ltd.